#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paget's disease of the vulva Dermatomyositis Immunoglobulin G4 related disease Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Neuroblastoma recurrent Rheumatoid arthritis Lymphangiosarcoma Rosai-Dorfman syndrome PIK3CA related overgrowth spectrum Thymic carcinoma Ocular lymphoma Juvenile idiopathic arthritis Nephrotic syndrome Clear cell papillary renal cell carcinoma Richter's syndrome More trials…

    Learn about Rare Diseases

    Stevens-Johnson syndrome – Trials in Disease Progressive supranuclear palsy – Life with Disease Hypereosinophilic syndrome Paroxysmal nocturnal haemoglobinuria – Trials in Disease Toxic epidermal necrolysis Optic glioma – Treatment Crigler-Najjar syndrome – Diagnostics Marfan’s syndrome – Basic Information Paraneoplastic neurological syndrome Urea cycle disorder – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ponatinib Fluvastatin Sodium GSKVX000000030825 Immunoglobulin G Gsk3739937 Ketamine Hydrochloride Savolitinib Neflamapimod Nelivaptan Desflurane Copanlisib Dihydrochloride Benfotiamine Gemlapodect Pazopanib Rituximab Glutathione Resiniferatoxin BIIB115 Cedazuridine Mometasone Furoate Monohydrate More therapies…

    Learn about Your Condition

    Oxygen therapy Ulcerative keratitis Hepatic encephalopathy Diabetes insipidus Rabies Ovarian epithelial cancer Papillary thyroid cancer Vascular calcification Chronic coronary syndrome Prinzmetal angina Small intestine adenocarcinoma Post cardiac arrest syndrome Lymphangioleiomyomatosis Acute lymphocytic leukaemia Arrhythmia supraventricular More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Departemental Vendee

Centre Hospitalier Departemental Vendee

Boulevard Stephane Moreau, La Roche sur Yon, 85925, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Rivaroxaban and Drug Combination for Preventing Blood Clots in Patients with Lower Limb Injuries Requiring Immobilization

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Joint stabilisation
    Investigated Drugs:
    • Dalteparin Sodium
    • Nadroparin Calcium
    • Tinzaparin Sodium
    France

  • Study Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ibrutinib
    • Pirtobrutinib
    Austria Belgium Czechia France Germany Hungary +3

  • Study on Baricitinib and Anti-TNF Drug Combination for Patients with Rheumatoid Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Etanercept
    • Adalimumab
    • Baricitinib
    France

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Elranatamab
    • Carfilzomib
    • Elotuzumab
    Belgium Croatia Czechia Denmark Finland France +10

  • Study on Using Desmopressin Acetate Trihydrate to Prevent Sodium Overcorrection in Patients with Severe Hyponatremia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Meglumine Gadoterate
    • Glucose Monohydrate
    • Sodium Lactate
    France

  • Study on the Safety and Effectiveness of Apixaban and Warfarin for Patients with End-Stage Renal Disease on Peritoneal Dialysis and Atrial Fibrillation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Warfarin
    • Warfarin Sodium
    • Apixaban
    France

  • Study on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Goserelin
    • Triptorelin
    • Degarelix
    Belgium France Ireland Spain

  • Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Balcinrenone
    • Dapagliflozin
    Austria Bulgaria Czechia Finland France Germany +9

  • Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    France Italy

  • Study Comparing Vedolizumab and Adalimumab for Crohn’s Disease Patients Who No Longer Respond to Adalimumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Adalimumab
    • Vedolizumab
    France
Previous Page
1 … 5 6 7 8 9 … 21
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!